SCHEMBL30890705

SCHEMBL30890705

Cc1cnc2c(c1)NC(=O)[C@@]1(C[C@@H](C(N)=O)N(C(=O)[C@H](CC3CC3)N(C)C(=O)[C@H](CC3CC3)NC(=O)OC(C)(C)C)C1)O2

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 1/20 0.32
▸ CTSS P25774 1/20 0.30
▸ CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890631 1.00 AAK1 (0.32) AAK1CTSSCTSK
SCHEMBL27245152 0.90 — —
SCHEMBL27245156 0.90 — —
SCHEMBL30890602 0.90 CNR2 (0.32) —
SCHEMBL30890807 0.90 CNR2 (0.32) —
SCHEMBL30890716 0.88 AAK1 (0.32) AAK1CTSSCTSK
SCHEMBL27244675 0.86 CNR2 (0.33) —
SCHEMBL27244681 0.86 CNR2 (0.33) —
SCHEMBL30992258 0.85 AAK1 (0.34) AAK1CTSSCTSK
SCHEMBL27244872 0.85 CNR2 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback